The IIT Study of Evaluation of P-IL-2 Single Agent and With Anti-PD-1

NCT05829057 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Esophagus Cancer
Bladder Cancer
Liver Cancer
Ovarian Cancer
Small-cell Lung Cancer

Interventions

BIOLOGICAL: Intravenous injection of P-IL-2
BIOLOGICAL: P-IL-2 plus Anti-PD-1 Monoclonal Antibody

Sponsor

Zhejiang University

Collaborators

[object Object]